Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04526990
Recruitment Status : Active, not recruiting
First Posted : August 26, 2020
Last Update Posted : October 31, 2022
Beijing Institute of Biotechnology
Information provided by (Responsible Party):
CanSino Biologics Inc.